)
)
Paratek Pharmaceuticals Investor Relations Material
Latest events
Q1 2023
Paratek Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Paratek Pharmaceuticals Inc
Access all reports
Paratek Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for infectious diseases. The company specializes in antibiotics that address serious bacterial infections, including drug-resistant strains. Paratek's products are designed to provide effective treatment options for conditions such as skin infections and community-acquired bacterial pneumonia. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
PRTK
Country
🇺🇸 United States